Dalia A. Elzahaby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dalia A. Elzahaby has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Eman A. Helmy
Regional Center for Mycology and Biotechnology (RCMB), Al-Azhar University, Cairo, Egypt
1 shared publication- Farag M. Mosallam
Drug Radiation Research Department, Drug Microbiology Lab, Biotechnology Division, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt
1 shared publication - Hala A. Farrag
National Centre for Radiation Research and Technology (NCRRT), Drug Radiation Research Department, Egyptian Atomic Energy Authority (EAEA), Nasr City, Egypt
1 shared publication Marwa M. Helal
Regional Center for Mycology and Biotechnology (RCMB), Al-Azhar University, Cairo, Egypt
1 shared publication- Mohamed H. Alkordi
Center for Material Science, Zewail City of Science and Technology, Giza 12578, Egypt
1 shared publication - Mohammed A. Ramadan
Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
Targeting Pathogenic Infection and Virulence Genes of Enterococcus Faecalis Using Lactoferrin Bismuth Nano-form
Enterococcus faecalis ( E. faecalis ) is an opportunistic pathogen associated with severe infections, particularly in hospital settings. Increasing antibiotic resistance and diverse virulence factors highlights the urgent need for innovative, effective therapeutic approaches. In this study, a lactoferrin–Bismuth Nanoform (LF-Bi-NF) was synthesized and comprehensively characterized using UV–visible spectroscopy, scanning electron microscopy (SEM), energy-dispersive X-ray (EDX) mapping, dynamic light scattering (DLS), and Fourier-transform infrared (FTIR) spectroscopy. However, gamma radiation negatively impacted the stability of LF-Bi-NF. The LF-Bi-NF was evaluated against pathogenic E. faecalis isolates through in vitro assays, in addition to in vivo investigations in orally infected mice. The LF-Bi-NF exhibited antibacterial activity, with inhibition zones of 20.0 ± 0.10, 21.0 ± 0.15, 18.0 ± 0.25, and 15.0 ± 0.31 mm against E. faecalis _1, E. faecalis _2, E. faecalis _3, and E. faecalis ATCC 29212, respectively. While both lactoferrin and bismuth salts alone exhibited no detectable activity. The LF-Bi-NF demonstrated minimum inhibitory concentrations (MICs) of 3.125, 1.56, 6.25, and 12.5 µg/mL and minimum bactericidal concentrations (MBCs) of 12.50, 3.125, 25, and 25 µg/mL against the respective isolates, along with inhibition of biofilm formation at sub-MIC levels. Mechanistic investigations indicated disruption of cell wall integrity, increased membrane permeability, and protein leakage, particularly in the strong biofilm-forming isolate E. faecalis _2. Additionally, gene expression analysis showed that the antibiotic resistance associated genes norA, ermC , and EF3314 were downregulated by 64%, 59%, and 87%, respectively. In vivo studies demonstrated that LF-Bi-NF treatment promoted recovery in infected mice, improved immunological biomarkers (IL-12, IL-10, MPO, and IFN-γ), and significantly reduced bacterial burden in the bloodstream to undetectable levels within four days. In conclusion, LF-Bi-NF represents a promising nano-therapeutic candidate for the treatment of E. faecalis infections, exhibiting strong antibacterial, anti-biofilm, anti-virulence, and immunomodulatory properties.
- 9 June 2026
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
Open AccessTargeting Pathogenic Infection and Virulence Genes of Enterococcus Faecalis Using Lactoferrin Bismuth Nano-form
Enterococcus faecalis ( E. faecalis ) is an opportunistic pathogen associated with severe infections, particularly in hospital settings. Increasing antibiotic resistance and diverse virulence factors highlights the urgent need for innovative, effective therapeutic approaches. In this study, a lactoferrin–Bismuth Nanoform (LF-Bi-NF) was synthesized and comprehensively characterized using UV–visible spectroscopy, scanning electron microscopy (SEM), energy-dispersive X-ray (EDX) mapping, dynamic light scattering (DLS), and Fourier-transform infrared (FTIR) spectroscopy. However, gamma radiation negatively impacted the stability of LF-Bi-NF. The LF-Bi-NF was evaluated against pathogenic E. faecalis isolates through in vitro assays, in addition to in vivo investigations in orally infected mice. The LF-Bi-NF exhibited antibacterial activity, with inhibition zones of 20.0 ± 0.10, 21.0 ± 0.15, 18.0 ± 0.25, and 15.0 ± 0.31 mm against E. faecalis _1, E. faecalis _2, E. faecalis _3, and E. faecalis ATCC 29212, respectively. While both lactoferrin and bismuth salts alone exhibited no detectable activity. The LF-Bi-NF demonstrated minimum inhibitory concentrations (MICs) of 3.125, 1.56, 6.25, and 12.5 µg/mL and minimum bactericidal concentrations (MBCs) of 12.50, 3.125, 25, and 25 µg/mL against the respective isolates, along with inhibition of biofilm formation at sub-MIC levels. Mechanistic investigations indicated disruption of cell wall integrity, increased membrane permeability, and protein leakage, particularly in the strong biofilm-forming isolate E. faecalis _2. Additionally, gene expression analysis showed that the antibiotic resistance associated genes norA, ermC , and EF3314 were downregulated by 64%, 59%, and 87%, respectively. In vivo studies demonstrated that LF-Bi-NF treatment promoted recovery in infected mice, improved immunological biomarkers (IL-12, IL-10, MPO, and IFN-γ), and significantly reduced bacterial burden in the bloodstream to undetectable levels within four days. In conclusion, LF-Bi-NF represents a promising nano-therapeutic candidate for the treatment of E. faecalis infections, exhibiting strong antibacterial, anti-biofilm, anti-virulence, and immunomodulatory properties.
- Open Access
- 31 March 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (4) , 913
Inhibition of Adherence and Biofilm Formation of Pseudomonas aeruginosa by Immobilized ZnO Nanoparticles on Silicone Urinary Catheter Grafted by Gamma Irradiation
Nosocomial infections caused by microbial biofilm formation on biomaterial surfaces such as urinary catheters are complicated by antibiotic resistance, representing a common problem in hospitalized patients. Therefore, we aimed to modify silicone catheters to resist microbial adherence and biofilm formation by the tested microorganisms. This study used a simple direct method to graft poly-acrylic acid onto silicone rubber films using gamma irradiation to endow the silicone surface with hydrophilic carboxylic acid functional groups. This modification allowed the silicone to immobilize ZnO nanoparticles (ZnO NPs) as an anti-biofilm. The modified silicone films were characterized by FT-IR, SEM, and TGA. The anti-adherence ability of the modified silicone films was evidenced by the inhibition of biofilm formation by otherwise strong biofilm-producing Gram-positive, Gram-negative, and yeast clinical isolates. The modified ZnO NPs grafted silicone showed good cytocompatibility with the human epithelial cell line. Moreover, studying the molecular basis of the inhibitory effect of the modified silicone surface on biofilm-associated genes in a selected Pseudomonas aeruginosa isolate showed that anti-adherence activity might be due to the significant downregulation of the expression of lasR, lasI, and lecB genes by 2, 2, and 3.3-fold, respectively. In conclusion, the modified silicone catheters were low-cost, offering broad-spectrum anti-biofilm activity with possible future applications in hospital settings.
- 31 March 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (4) , 913
Open AccessInhibition of Adherence and Biofilm Formation of Pseudomonas aeruginosa by Immobilized ZnO Nanoparticles on Silicone Urinary Catheter Grafted by Gamma Irradiation
Nosocomial infections caused by microbial biofilm formation on biomaterial surfaces such as urinary catheters are complicated by antibiotic resistance, representing a common problem in hospitalized patients. Therefore, we aimed to modify silicone catheters to resist microbial adherence and biofilm formation by the tested microorganisms. This study used a simple direct method to graft poly-acrylic acid onto silicone rubber films using gamma irradiation to endow the silicone surface with hydrophilic carboxylic acid functional groups. This modification allowed the silicone to immobilize ZnO nanoparticles (ZnO NPs) as an anti-biofilm. The modified silicone films were characterized by FT-IR, SEM, and TGA. The anti-adherence ability of the modified silicone films was evidenced by the inhibition of biofilm formation by otherwise strong biofilm-producing Gram-positive, Gram-negative, and yeast clinical isolates. The modified ZnO NPs grafted silicone showed good cytocompatibility with the human epithelial cell line. Moreover, studying the molecular basis of the inhibitory effect of the modified silicone surface on biofilm-associated genes in a selected Pseudomonas aeruginosa isolate showed that anti-adherence activity might be due to the significant downregulation of the expression of lasR, lasI, and lecB genes by 2, 2, and 3.3-fold, respectively. In conclusion, the modified silicone catheters were low-cost, offering broad-spectrum anti-biofilm activity with possible future applications in hospital settings.